Anna Marie Wagner



Anna Marie Wagner is the SVP of Corporate Development for Ginkgo Bioworks. Ginkgo is a synthetic biology company that genetically engineers "made-to-order" microbes for customers across industries, including industrial chemicals, pharmaceuticals, food and agriculture, and personal care.  Ginkgo designs these microbes in a 100K+ sqft Boston facility that brings scale economics to biological engineering using robotic automation and custom software.  The company has raised over $800M in venture capital funding and has partnerships with companies including Bayer, ADM, Cargill, Genomatica, Cronos, Roche, Synlogic, and Moderna. Prior to joining Ginkgo Bioworks, Anna Marie was an investor at Bain Capital Private Equity.  She holds a B.A. in Applied Mathematics and Economics from Harvard and an M.B.A. from Harvard Business School, where she was a Baker Scholar.